Morphine methylbromide

Morphine methylbromide
Clinical data
Other namesMorphine bromomethylate; Morphine methobromide; Morphosan
Legal status
Legal status
Identifiers
IUPAC name
  • (5α,6α)-3,6-Dihydroxy-17,17-dimethyl-7,8-didehydro-4,5-epoxymorphinan-17-ium bromide
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC18H22BrNO3
Molar mass380.282 g·mol−1
3D model (JSmol)
SMILES
  • [H][C@]1([C@@H](O)C=C2)[C@]([C@]2([H])[C@H]3C4)(CC[N+]3(C)C)C5=C4C=CC(O)=C5O1.[Br-]
InChI
  • InChI=1S/C18H21NO3.BrH/c1-19(2)8-7-18-11-4-6-14(21)17(18)22-16-13(20)5-3-10(15(16)18)9-12(11)19;/h3-6,11-12,14,17,21H,7-9H2,1-2H3;1H/t11-,12+,14-,17-,18-;/m0./s1
  • Key:KQUQZJSQMSHWHP-SCLAZZCHSA-N

Morphine methylbromide (Morphine methobromide, Morphine bromomethylate, Morphosan) a derivative of morphine. It is an opioid listed as a Schedule I Narcotic with an ACSCN of 9305 and a 2014 aggregate national production quota of 5 grams. It is a salt of morphine with a freebase conversion ratio of 0.75.controlled substance.[1] [2]

References

  1. 21 CFR 1308.11
  2. "DEA Diversion Control Division". www.deadiversion.usdoj.gov. Retrieved 2021-02-16.



This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.